Author response to: Comment on: Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study)
Br J Surg. 2024 Jun 12;111(6):znae146.
doi: 10.1093/bjs/znae146.